We are live on ! Find out more
GLRA

Gerald L. Ray & Associates Portfolio holdings

AUM $802M
1-Year Est. Return 21.01%
This Fund
S&P 500
This Quarter Est. Return
+1.97%
1 Year Est. Return
+21.01%
3 Year Est. Return
+38.23%
5 Year Est. Return
10 Year Est. Return
AUM
$665M
AUM Growth
+$14.2M
Cap. Flow
+$8.27M
Cap. Flow %
1.24%
Top 10 Hldgs %
29.06%
Holding
320
New
17
Increased
94
Reduced
63
Closed
8

Sector Composition

Rank Sector Weight
1 Healthcare 24.19%
2 Industrials 14.52%
3 Consumer Staples 10.31%
4 Energy 8.33%
5 Technology 8.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MMP
26
DELISTED
Magellan Midstream Partners, L.P.
MMP
$6.33M 0.95%
82,574
XOM icon
27
ExxonMobil
XOM
$650B
$6.33M 0.95%
74,489
+212
+0.3% +$18.8K
C icon
28
Citigroup
C
$213B
$6.33M 0.95%
122,783
+778
+0.6% +$39.6K
SNDK
29
DELISTED
SANDISK CORP
SNDK
$6.27M 0.94%
98,591
+2,632
+3% +$214K
BA icon
30
Boeing
BA
$169B
$5.85M 0.88%
38,992
+1
+0% +$146
EPD icon
31
Enterprise Products Partners
EPD
$83.7B
$5.67M 0.85%
172,196
+1,050
+0.6% +$35.2K
PM icon
32
Philip Morris
PM
$309B
$5.6M 0.84%
74,297
+450
+0.6% +$36.5K
GILD icon
33
Gilead Sciences
GILD
$165B
$5.35M 0.8%
54,480
-600
-1% -$60.9K
IBM icon
34
IBM
IBM
$213B
$5.18M 0.78%
33,744
-2,186
-6% -$332K
KSU
35
DELISTED
Kansas City Southern
KSU
$4.88M 0.73%
47,840
SPG icon
36
Simon Property Group
SPG
$76.4B
$4.76M 0.72%
24,346
-66
-0.3% -$12.8K
VRTX icon
37
Vertex Pharmaceuticals
VRTX
$123B
$4.73M 0.71%
40,130
-4,100
-9% -$491K
CSCO icon
38
Cisco
CSCO
$443B
$4.62M 0.7%
167,937
+555
+0.3% +$15.6K
MSFT icon
39
Microsoft
MSFT
$2.9T
$4.57M 0.69%
112,511
-192
-0.2% -$8.36K
TMO icon
40
Thermo Fisher Scientific
TMO
$214B
$4.55M 0.69%
33,896
+150
+0.4% +$19.3K
MRK icon
41
Merck
MRK
$322B
$4.52M 0.68%
82,346
+88
+0.1% +$4.98K
CAT icon
42
Caterpillar
CAT
$361B
$4.46M 0.67%
55,783
+1,848
+3% +$154K
RTX icon
43
RTX Corp
RTX
$290B
$4.43M 0.67%
60,039
+11,037
+23% +$824K
EL icon
44
Estee Lauder
EL
$30.4B
$3.76M 0.57%
45,234
ESRX
45
DELISTED
Express Scripts Holding Company
ESRX
$3.75M 0.56%
43,157
CVX icon
46
Chevron
CVX
$382B
$3.64M 0.55%
34,647
-46
-0.1% -$4.91K
EOG icon
47
EOG Resources
EOG
$77.7B
$3.3M 0.5%
36,000
+9,025
+33% +$815K
ACAD icon
48
Acadia Pharmaceuticals
ACAD
$4.51B
$3.25M 0.49%
99,750
+1,500
+2% +$51.6K
FDX icon
49
FedEx
FDX
$73B
$3.22M 0.48%
19,446
-315
-2% -$54.7K
QQQ icon
50
Invesco QQQ Trust
QQQ
$436B
$3.22M 0.48%
30,459
-233
-0.8% -$24.5K

Similar funds

Gerald L. Ray & Associates's Q1 2015 Portfolio in Review

As of Q1 2015, Gerald L. Ray & Associates held 320 positions worth $665M, up 2.2% from $650M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Gerald L. Ray & Associates's Q1 2015 filing shows 17 new, 94 increased, 63 reduced and 8 closed positions. Its largest new stake was Williams Partners L.P.: 18,217 shares worth $897K. The largest sale was PHARMACYCLICS INC, an estimated $888K.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 24% a quarter earlier, followed by Industrials and Consumer Staples.

  • Gerald L. Ray & Associates's largest Q1 2015 buy was Williams Partners L.P.: 18,217 shares worth $897K.
  • Gerald L. Ray & Associates added most to Ford in Q1 2015, an estimated $1M increase.
  • Gerald L. Ray & Associates's biggest Q1 2015 reduction was Regeneron Pharmaceuticals, cutting an estimated $532K.
  • Gerald L. Ray & Associates fully exited PHARMACYCLICS INC in Q1 2015, selling an estimated $888K.
  • Gerald L. Ray & Associates's ten largest holdings make up 29% of its $665M portfolio in Q1 2015.
  • Gerald L. Ray & Associates opened 17 new positions and closed 8 in Q1 2015.
  • Gerald L. Ray & Associates's portfolio value rose 2.2% quarter-over-quarter to $665M.

Based on Gerald L. Ray & Associates's 13F filing for Q1 2015, filed 6 May 2015.